Benjamin Brannick, MD
Endocrinology, Diabetes & Metabolism · Memphis, TNNPI 1679718357
Payments from drug & device makers
Across 1,132 payments — averaging $73.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xeris Pharmaceuticals, Inc.$42K
- Sanofi-aventis U.S. LLC$19K
- Corcept Therapeutics$3K
- Novo Nordisk$3K
- AstraZeneca$2K
- Lilly USA, LLC$2K
- plus $13K from 48 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$83,681 in reported general payments places this provider in the 75th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Memphis
- Lisa UsdanMemphis$14.3M
- Pedro VelasquezMemphis$2.4M
- Alan CohenMemphis$1.5M
- Aidar GosmanovMemphis$833K
- Shimon HararyMemphis$735K
- Samuel Dagogo-JackMemphis$476K
- Ebenezer NyenweMemphis$438K
- Richard ChildressMemphis$212K
- Deirdre JamesMemphis$92K
- Malini GuptaMemphis$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.